Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
3.600
+0.050 (1.41%)
Sep 26, 2025, 3:00 PM CST
SHA:600664 Market Cap
SHA:600664 has a market cap or net worth of 9.07 billion as of September 26, 2025. Its market cap has increased by 13.92% in one year.
Market Cap
9.07B
Enterprise Value
8.06B
Revenue
16.16B
Ranking
n/a
PE Ratio
17.09
Stock Price
3.60
Market Cap Chart
Since August 28, 2006, SHA:600664's market cap has increased from 7.45B to 9.07B, an increase of 21.67%. That is a compound annual growth rate of 1.03%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 9.07B | -12.83% |
Dec 31, 2024 | 10.40B | 23.17% |
Dec 29, 2023 | 8.45B | 11.14% |
Dec 30, 2022 | 7.60B | -15.00% |
Dec 31, 2021 | 8.94B | 11.79% |
Dec 31, 2020 | 8.00B | -15.83% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 467.24B |
WuXi AppTec | 299.67B |
Shenzhen Mindray Bio-Medical Electronics | 288.50B |
Sichuan Biokin Pharmaceutical | 149.53B |
Zhangzhou Pientzehuang Pharmaceutical., | 119.01B |
Shanghai United Imaging Healthcare | 118.35B |
Aier Eye Hospital Group | 114.80B |
Yunnan Baiyao Group Co.,Ltd | 101.90B |